Prescribing pattern of antidiabetic drugs in Indore city hospital

Indian Journal of Pharmaceutical Sciences

Volumn 70, Issue 5, 2008, Pages 637-640

  Vengurlekar, Sudha ^a   Shukla, Prerna ^a   Patidar, P ^a   Bafna, R ^a   Jain, S ^a  

^a Smriti College of Pharmaceutical Education   (India)

Author keywords

Diabetes; Inpatient; Outpatient; Prescription Auditing

Indexed keywords

ANTIDIABETIC AGENT; GLIMEPIRIDE; GLIMEPIRIDE PLUS METFORMIN; GLIMEPIRIDE PLUS PIOGLITAZONE; INSULIN; METFORMIN; METFORMIN PLUS PIOGLITAZONE; MIGLITOL; PIOGLITAZONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG MARKETING; FEMALE; GROUPS BY AGE; HUMAN; HYPERTENSION; INDIA; INFANT; MALE; MEDICAL PRACTICE; MEDICAL RECORD; PATIENT MONITORING; PRESCHOOL CHILD; PRESCRIPTION; PREVALENCE; PROFESSIONAL PRACTICE; SCHOOL CHILD; SEX RATIO; WORLD HEALTH ORGANIZATION;

EID: 60249084496     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.45404     Document Type: Article

References (12)

1. Tripathi KD. Essential of medical pharmacology. 4th ed. New Delhi: Jaypee Brother Medical Publishers; 2001. p. 264-83.
2. Davis SN, Granner DK. Insulin, oral hypoglycemic agents and the pharmacology of the endocrine pancreas In: Hardman JG, Limbird LE, Gilman AG, editors. Goodman and Gilman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw Hill Professional; 2001. p. 1679-714.
3. The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classifications of diabetes mellitus. Diabetes Care 1997;20:1183-97.
4. Rang HP, Dale MM Ritter JM, Moore PK. Pharmacology. 5th ed. Sydney: Churchill Livingstone; 2003. p. 315-22.
5. Knowles WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
6. Bakassas I, Lunde PK. National drug policies: The need for drug utilization studies. Trends Pharmacol Sci 1986;7:331-4.
7. WHO, How to investigate drug use in health facilities: Selected drug use indicators. Geneva: World Health Organization; 1993. WHO/DAP1993:1:1-87.
8. Definition, diagnosis and classification of diabetes mellitus: Report of WHO consultation. (Publication W.H.O./ NCD/99.2). Geneva, Switzerland: World Health Organization; 1999.
9. Hermann LS, Schersten B, Bitzen PO, Kjellstrom T, Lindgarde F, Melander A. Therapeutics comparison of metformin and sulphonylurea alone and in combinations: A double blind controlled study. Diabetes Care 1994;17:1100-9.
10. Krentz AJ, Bailey CJ. Oral antidiabetic agents: Current role in type 2 diabetes mellitus. Drugs 2005;65:385-411.
11. Riddle MC. Oral pharmacologic management of type 2 diabetes. Am Fam Physician 1999;60:2613-20.
12. Shashikiran U, Vidyasagar S, Prabhu MM. Diabetes in the elderly. Int J Geriatr Gerontol 2004;1:2.